Medstar Union Memorial Hospital

Summary

Medstar Union Memorial Hospital is a medical facility located in Baltimore, Maryland. This center is recognized for care of Coronary Artery Disease, Lung Cancer, Breast Cancer, Myocardial Ischemia, Von Willebrand Disease and other specialties. Medstar Union Memorial Hospital is involved with conducting 105 clinical trials across 205 conditions. There are 4 research doctors associated with this hospital, such as John Wang, MD, Shawna Willey, MD, Brain Bethea, MD, and Sandeep Jani, MD.

Top PIs

Clinical Trials running at Medstar Union Memorial Hospital

Atrial Fibrillation

Stroke

High Blood Pressure

Von Willebrand Disease

Heart Failure

Aortic Regurgitation

Mitral Regurgitation

Mitral Valve Regurgitation

Bleeding

Hemorrhage

Pacing Rates

for Atrial Fibrillation

This is a prospective, randomized crossover study. The objective of the study is to determine if a pacing rate of 80 beats per minute (bpm) improves exercise tolerance during the 6-minute walk test. The investigators will randomly assign half of the participants to a starting rate of 60 bpm and then switch them to a rate of 80 bpm for 3 months, and vice versa.

Recruiting

1 award

N/A

3 criteria

Left Atrial Appendage Occlusion vs. NOAC

for Atrial Fibrillation

The objective of this trial is to evaluate the safety and effectiveness of the Amulet LAA occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for ischemic stroke and who are recommended for long-term NOAC therapy. The clinical investigation is a prospective, randomized, multicenter active control worldwide trial. Subjects will be randomized in a 1:1 ratio between the Amulet LAA occlusion device ("Device Group") and a commercially available NOAC medication ("Control Group"). The choice of NOAC in the Control Group will be left to study physician discretion.

Recruiting

1 award

N/A

8 criteria

CLAAS Device

for Atrial Fibrillation

This trial is testing a new heart device called the CLAAS® to see if it works as well as other similar devices. It is aimed at patients with a specific type of irregular heartbeat that can lead to strokes. The device helps by blocking off a small part of the heart to stop blood clots from forming.

Recruiting

1 award

N/A

8 criteria